Marginal Zone B-cell Lymphoma
📧 Sign up to get email alerts when something new happens for Marginal Zone B-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Bendamustine Plus Rituximab (BR) for Relapsed or Progressive Marginal Zone B-cell Lymphoma (MZBCL) [Phase 2]
Phase 2 clinical trial of Bendamustine plus Rituximab for relapsed or progressive marginal zone B-cell lymphoma has completed and results ha…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: CD20 Monoclonal Antibody-Based First-Line Therapy in Treatment-Naive Marginal Zone B-Cell Lymphoma
A clinical trial conducted at Henan Cancer Hospital is evaluating a CD20 monoclonal antibody-based first-line therapy for treatment-naive ma…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: A Study to Evaluate MTM-H-001 Injection in Adult Participants With Relapsed or Refractory B-cell Malignancies [NA]
This clinical trial update describes an evaluation of MTM-H-001 injection in adults with relapsed or refractory B-cell lymphomas, with the s…
-
CLINICAL_TRIALS trial_result · 2025-06-17Clinical Trial Update: JWCAR239 in Patients With B Cell Non-Hodgkin Lymphoma [Phase 1]
Phase 1 study of JWCAR239 for B-cell non-Hodgkin lymphoma is not yet recruiting, with indications including diffuse large B-cell lymphoma, f…
-
CLINICAL_TRIALS trial_result · 2024-07-16Clinical Trial Update: A Study of LOXO-305 in Chinese Participants With Blood Cancer (Including Lymphoma and Chronic Leukemia) [Phase 2]
Phase 2 clinical trial update on LOXO-305 (pirtobrutinib) in Chinese participants with B-cell malignancies, with results posted on July 16, …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-02-09Clinical Trial Update: Vincristine Sulfate Liposome Injection (Marqibo®), Bendamustine and Rituximab-Phase I Trial in Indolent B-cell Lymphoma [Phase 1]
Phase I trial evaluating a combination of Vincristine Sulfate Liposome Injection with Bendamustine and Rituximab in indolent B-cell lymphoma…
-
CLINICAL_TRIALS trial_result · 2023-02-01Clinical Trial Update: Bendamustine and Rituximab for the Treatment of Splenic Marginal Zone Lymphoma [Phase 2]
Phase 2 trial evaluating bendamustine and rituximab for splenic marginal zone lymphoma has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-05-07Clinical Trial Update: Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas [Phase 2]
Phase 2 trial evaluating lenalidomide with low-dose dexamethasone and rituximab in rituximab-resistant, non-aggressive B-cell lymphomas; com…
-
CLINICAL_TRIALS trial_result · 2018-07-02Clinical Trial Update: CPI-613, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma [Phase 1]
Phase 1 trial evaluating a triple regimen of devimistat (CPI-613), bendamustine hydrochloride, and rituximab in relapsed or refractory B-cel…
-
CLINICAL_TRIALS research · 2018-04-18Clinical Trial Update: Marginal Zone Lymphoma Cohort in Korea
An update on the Marginal Zone B-cell lymphoma cohort enrolled in Korea for the ongoing clinical trial.
-
CLINICAL_TRIALS trial_result · 2017-05-22Clinical Trial Update: Rituximab in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant for Relapsed or Refractory B-cell Lymphoma [Phase 2]
Phase 2 trial evaluating rituximab in patients undergoing donor peripheral blood stem cell transplantation for relapsed or refractory B-cell…
-
CLINICAL_TRIALS trial_result · 2016-12-22Clinical Trial Update: A Phase II Study of Doxycycline in Relapsed NHL [Phase 2]
Phase II trial of doxycycline in relapsed non-Hodgkin lymphoma was terminated and results were posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-04-11Clinical Trial Update: Rituximab Maintenance Therapy for Marginal Zone B-cell Lymphoma (MZL) [Phase 2]
Phase 2 study evaluating Rituximab as maintenance therapy for marginal zone B-cell lymphoma has completed.
-
CLINICAL_TRIALS withdrawal · 2015-10-12Clinical Trial Update: Ofatumumab In Older Patients With Untreated Low Or Intermediate Risk Indolent B-Cell Lymphomas [Phase 2]
This clinical trial update notes that the Phase 2 study of the anti-CD20 antibody ofatumumab in older patients with untreated indolent B-cel…
-
CLINICAL_TRIALS trial_result · 2014-03-20Clinical Trial Update: A Study of SGN-40 in Combination With Rituximab in Patients With CD20-Positive, Follicular and Marginal Zone B-Cell Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 study evaluating SGN-40 in combination with Rituximab in CD20-positive follicular and marginal zone B-cell non-Hodgkin's lymphoma ha…
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: Multicenter Phase II Study to Evaluate the Clinical Activity and the Safety Profile of Everolimus in Marginal Zone B-cell Lymphomas (MZL) [Phase 2]
A multicenter Phase II study evaluated the activity and safety of everolimus in patients with marginal zone B-cell lymphoma (MZL) and has co…
-
CLINICAL_TRIALS trial_result · 2012-09-05Clinical Trial Update: 131I-rituximab for Relapsed or Refractory Marginal Zone B-cell Lymphoma [Phase 2]
Phase 2 clinical trial update of 131I-rituximab for relapsed or refractory marginal Zone B-cell lymphoma; current trial status is unknown.